Entera Bio Ltd. Files 8-K on Warrants and Operations

Ticker: ENTX · Form: 8-K · Filed: Jul 28, 2025 · CIK: 1638097

Entera Bio LTD. 8-K Filing Summary
FieldDetail
CompanyEntera Bio LTD. (ENTX)
Form Type8-K
Filed DateJul 28, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: warrants, corporate-filing, biological-products

Related Tickers: ENTX, ENTXW

TL;DR

Entera Bio's 8-K is out: warrants at $5.85, Israel-based bio company.

AI Summary

Entera Bio Ltd. filed an 8-K on July 28, 2025, reporting on various events. The filing includes information about warrants exercisable for Ordinary Shares at an exercise price of $5.85 per share. It also details the company's incorporation in Israel and its primary business in biological products.

Why It Matters

This filing provides updates on Entera Bio's financial instruments and corporate structure, which are important for investors to understand potential share dilution and the company's operational status.

Risk Assessment

Risk Level: medium — The filing mentions warrants with an exercise price, which could lead to dilution if exercised, impacting existing shareholders.

Key Numbers

Key Players & Entities

FAQ

What is the exercise price for the Entera Bio Ltd. warrants?

The warrants are exercisable for Ordinary Shares at an exercise price of $5.85 per Ordinary Share.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on July 28, 2025.

In which country is Entera Bio Ltd. incorporated?

Entera Bio Ltd. is incorporated in Israel.

What is the primary industry of Entera Bio Ltd.?

Entera Bio Ltd. is in the Biological Products industry.

What is the ticker symbol associated with Entera Bio Ltd.'s warrants?

The ticker symbol associated with Entera Bio Ltd.'s warrants is ENTXW.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 28, 2025 regarding Entera Bio Ltd. (ENTX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing